Wellfully Limited (WFL.AX)

0.0370 -0.0030 (-7.50%) At close: 03:54PM AEST

Wellfully Limited

284 Oxford Street
Ground Floor
Leederville, WA 6007
Australia
61 8 9443 3011
https://www.wellfully.net

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Paul Peros	Exec. Chairman & CEO	903.46k	N/A	N/A
Mr. Jeffrey David Edwards	Founder, MD, Technical Director & Exec. Director	235.05k	N/A	N/A
Mr. Sergej Dolezil	Chief Financial Officer	N/A	N/A	N/A
Dr. Matthew McIldowie	Chief Scientific Officer	N/A	N/A	N/A
Mr. Henko Vos C.A.	Company Sec.	N/A	N/A	N/A
Dr. Michael Roberts	Scientific Adviser	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Wellfully Limited, together with its subsidiaries, develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Singapore and Europe. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. It develops magnetic micro-array and powerless drug delivery technologies; and designs and develops drug patches, applicators, and brushes products. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.

Corporate governance

Wellfully Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.